166 related articles for article (PubMed ID: 16181753)
1. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
[TBL] [Abstract][Full Text] [Related]
2. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
3. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
4. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
Wu L; Al-Haydari M; da Rocha SR
Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.
Jones SA; Martin GP; Brown MB
J Pharm Sci; 2006 May; 95(5):1060-74. PubMed ID: 16552748
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
Marijani R; Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
[TBL] [Abstract][Full Text] [Related]
8. The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants.
Nyambura BK; Kellaway IW; Taylor KM
Int J Pharm; 2009 May; 372(1-2):140-6. PubMed ID: 19429273
[TBL] [Abstract][Full Text] [Related]
9. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
Berry J; Kline LC; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
[TBL] [Abstract][Full Text] [Related]
10. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
[TBL] [Abstract][Full Text] [Related]
11. Moisture uptake and its influence on pressurized metered-dose inhalers.
Williams RO; Hu C
Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
13. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
D'Sa D; Chan HK
Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
[TBL] [Abstract][Full Text] [Related]
14. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
15. The use of sodium carboxymethylcellulose in the preparation of spray-dried proteins for pulmonary drug delivery.
Li HY; Song X; Seville PC
Eur J Pharm Sci; 2010 Apr; 40(1):56-61. PubMed ID: 20188824
[TBL] [Abstract][Full Text] [Related]
16. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
17. The ester group: how hydrofluoroalkane-philic is it?
Peguin RP; Wu L; da Rocha SR
Langmuir; 2007 Jul; 23(16):8291-4. PubMed ID: 17602576
[TBL] [Abstract][Full Text] [Related]
18. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants.
Tan Y; Yang Z; Peng X; Xin F; Xu Y; Feng M; Zhao C; Hu H; Wu C
Int J Pharm; 2011 Jul; 413(1-2):167-73. PubMed ID: 21527322
[TBL] [Abstract][Full Text] [Related]
19. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.
Nyambura BK; Kellaway IW; Taylor KM
Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697
[TBL] [Abstract][Full Text] [Related]
20. Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers.
Jones SA; Martin GP; Brown MB
J Control Release; 2006 Sep; 115(1):1-8. PubMed ID: 16935379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
